Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Current Assets (2016 - 2025)

Historic Current Assets for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $449.2 million.

  • Veracyte's Current Assets rose 2588.45% to $449.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $449.2 million, marking a year-over-year increase of 2588.45%. This contributed to the annual value of $372.3 million for FY2024, which is 3033.6% up from last year.
  • Veracyte's Current Assets amounted to $449.2 million in Q3 2025, which was up 2588.45% from $414.7 million recorded in Q2 2025.
  • Veracyte's 5-year Current Assets high stood at $449.2 million for Q3 2025, and its period low was $229.3 million during Q3 2021.
  • Moreover, its 5-year median value for Current Assets was $285.6 million (2023), whereas its average is $306.4 million.
  • Data for Veracyte's Current Assets shows a peak YoY increase of 11503.87% (in 2021) and a maximum YoY decrease of 3807.76% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Veracyte's Current Assets stood at $243.1 million in 2021, then increased by 2.28% to $248.6 million in 2022, then rose by 14.88% to $285.6 million in 2023, then surged by 30.34% to $372.3 million in 2024, then rose by 20.67% to $449.2 million in 2025.
  • Its Current Assets stands at $449.2 million for Q3 2025, versus $414.7 million for Q2 2025 and $383.2 million for Q1 2025.